Click on a field for details on how to access that data via Web API, Excel, or CSV File Download.
| Open Price | |
| High Price | |
| Low Price | |
| Close Price | |
| Change | |
| Percent Change | |
| Volume |
| Avg Daily Volume | N/A |
| 52 Week High | $895.40 |
| 52 Week Low | $6.71 |
| Target Price | $30.00 |
| Ticker | CERO:UW |
| Composite Ticker | CERO:US |
| Security Name | CERo Therapeutics Holdings Inc. |
| Type | Ordinary Shares |
| Class | CERO |
| Currency | USD |
| Round Lot Size | N/A |
| Primary | Yes |
| Delisted | No |
| ETF | No |
| Market Category | Common Stock |
| Market Sector | Equity |
| Exchange Symbol | ^USCOMP |
| Exchange Name | US COMPOSITE |
| Exchange City | N/A |
| Exchange Country | UNITED STATES OF AMERICA |
| Exchange Website | N/A |
| FIGI | BBG012LSLGD6 |
| Composite FIGI | BBG012LSLG64 |
| Share Class FIGI | BBG012LSLH99 |
| FIGI Unique ID | N/A |
| Dividend | N/A |
| Dividend Rate | N/A |
| Trailing Dividend Yield | 0.00% |
| 5-year Average Dividend Yield | 0.00% |
| Dividend Ex Date | 2025-06-13 |
| Beta | -0.5569 |
| 1-year beta | -1.0947 |
| 3-year beta | -0.5569 |
| 5-year beta | 0.0079 |
| 7-year beta | 0.0079 |
| 10-year beta | 0.0079 |
Phoenix Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. It engages in identifying and acquiring a business that focuses on the healthcare or healthcare related industries in the United States and Europe. The company was incorporated in 2021 and is based in Oakland, California.
